Delphinus nabs $8 million for breast cancer detection device

May 25, 2010 By MedCity News

Delphinus Medical Technologies Inc. received $8 million in funding commitments to further develop an ultrasonic breast cancer detection device that could become an alternative to mammograms.

The funding means that Delphinus can finally begin the process of commercializing its SoftVue device, which has undergone about 10 years of research and development.

Unlike mammography, which is traditionally used to detect breast cancer, the SoftVue doesn’t use radiation or compression. Instead, the device employs ultrasound and computer algorithms to detect breast cancer, including in breast tissue that is too dense for effective use of mammography. With SoftVue, the breast is submerged in warm water and an ultrasound ring surrounds the breast, capturing images through the use of sound waves.

The SoftVue exam takes about a minute and is a “fraction” of the cost associated with a breast MRI, according to the company.

Delphinus is a spinoff created last year by the Detroit-based Barbara Ann Karmanos Cancer Institute, whose researchers created the device. The Karmanos Institute held all of Delphinus’ equity until the $8 million round, which was led by Arboretum Ventures of Ann Arbor, Mich. Farmington Hills, Mich.-based Beringea LLC co-led the deal and was joined by North Coast Technology Investors, according to a statement from Karmanos.

More than 300 women were involved in initial clinical studies of the device. Delphinus has received sale commitments for the device from “several” health institutions that have agreed to be part of the clinical studies, according to the statement.

Right now, the Karmanos Institute has the SoftVue’s only working prototype, but the funding will allow it to design and build the first 10 machines used in clinical studies. Those studies are expected to pave the way for Food & Drug Administration approval of the device, which is necessary before it can be sold in the U.S.

The funding will also allow Delphinus to hire about 20 workers.

The word “delphinus” is Latin for dolphin.

CVRx CEO details the path from being engineer to medtech executive
Nadim Yared, CEO of CVRx[/caption] This week, CVRX reported positive six-month trial results for its Barostim Neo, an FDA-approved treatment for heart failure. The results follow years of close work between the agency and CVRx, one of the more ambitious startups in medtech. CVRx is targeting a huge clinical need with novel neuromodulation technology. In… […]
What’s next for nitinol tubing?
Nitinol’s unique properties have made it the darling of the medical device industry. A novel technique for mechanically joining nitinol to other metal tubing could reduce cost and mitigate risk. Mark Broadley, Viant Nitinol has revolutionized the medical device industry. With its flexible superelasticity, shape memory and biocompatibility, nitinol has become a go-to material for… […]
Report: Haemonetics’ blood-collection devices could leave particles in donors
A consortium of news outlets is questioning the safety of Haemonetics (NYSE:HAE) blood-collection devices, claiming that particles have been detected in donors whose plasma was extracted by the machines. According to a report in the Miami Herald, whistleblower documents indicate that more than 150 Haemonetics customer reports have been made regarding the presence of particles by plasma collection centers and heathcare… […]
Spinal Elements’ cervical fixation system wins FDA nod
Spine surgery technology developer Spinal Elements announced today that it received FDA clearance for its Sapphire X product for anterior cervical fixation. Sapphire X is comprised of integrated instrumentation and high-angulation screws designed to help surgeons perform a procedure while preserving the patient’s skeletal and muscle tissue. The instrumentation is designed to reduce procedural steps… […]
How COVID-19 impacts FDA interactions with medical device manufacturers
By Stewart Eisenhart, Emergo Group The US Food and Drug Administration may revise performance goals and timelines set under the Medical Device User Fee Amendments IV (MDUFA IV) as emergency efforts targeting the coronavirus pandemic take up more of the agency’s time. Get the full story here at the Emergo Group’s blog. The opinions expressed… […]
Switchback Medical adds ‘sandbox approach’ to device testing
Contract manufacturer Switchback Medical (Maple Grove, Minn.) today announced that it has added a new division. Switchback BioSim Innovations offers functional dynamic biosimulator model development, cell culture services and physician training, according to the company. Biosimulator models use animal and human tissue to create functional models, such as a pumping heart with working valves to… […]
Smith College team wins ventilator design challenge
A team of Smith College engineering alumnae, staff and faculty has won the CoVent-19 Challenge to design a rapidly deployable ventilator to address shortages caused by the COVID-19 pandemic, particularly in developing countries. A dozen anesthesiology resident physicians from Massachusetts General Hospital kicked off the public challenge April 1, attracting 200 entries. The 30-person team… […]
FDA gives certain device makers more time to add UDIs
The FDA said today that it will grant manufacturers of Class 1 and unclassified medical devices and certain others more time to add unique device identifiers (UDIs) to their products. These companies will now have until Sept. 24, 2022 to comply with the agency’s UDI rule, including standard date formatting, labeling and Global Unique Device… […]
Eurofins launches 10-minute COVID-19 exposure testing device
Eurofins (Paris:ERF.PA) announced today that it launched its rapid point-of-care testing devices to identify past exposure to COVID-19. The serology-based, finger-prick tests detect antibodies with a sensitivity of 94.5% from 19 days following the onset of symptoms, with results coming in just 10 minutes, according to a news release. Get the full story at our sister site,… […]
How is RF technology shaping the future of medtech?
RF technology, including microwaves, isn’t just about wireless communications or military radar these days. Times Microwave Systems experts point out that it is increasingly important when it comes to medtech. Many medical electronics systems such as magnetic resonance imaging (MRI) systems for cancer detection rely on RF/microwave technology. Times Microwave Systems (Wallingford, Conn.) is hosting… […]
Medical device litigation and COVID-19: What you need to know
The COVID-19 pandemic is creating a new set of medical device litigation challenges — but also a chance for an industry reset. One of Greenberg Traurig’s top medtech litigation lawyers shares her insights. Sara Thompson doesn’t take any guff when she tells people that she defends medical device and pharmaceutical companies from lawsuits. “I say,… […]